Blue Sail Medical Co., Ltd. (002382.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 5.88

From 52W high−31.87%

Volume10.16M

Market capCNY 5.95B

P/E (TTM)−7.8x

P/S (TTM)1.0x

Div yield—

Key dataSep 18, 2026

Open

CNY 5.88

From 52W high

−31.87%

Volume

10.16M

Market cap

CNY 5.95B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4859.0x

P/E (TTM)

−7.8x

RSI (14)

47.0

MomentumView details →

1D Return

+0.17%

YTD Return

+4.46%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−7.8x

EV/EBITDA

−4859.0x

EV/Sales

1.3x

P/S (TTM)

1.0x

P/B (TTM)

0.9x

ProfitabilityView details →

Gross Margin

17.62%

Net Margin

−14.41%

EBITDA Margin

−0.03%

ROE (TTM)

−11.86%

ROA (TTM)

−5.22%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

−7.75%

EPS YoY

—

FCF YoY

+72.90%

Revenue CAGR 3Y

+5.41%

EPS CAGR 3Y

−72.73%

EBITDA YoY

—

MomentumView details →

1D Return

+0.17%

YTD Return

+4.46%

1Y Return

+1.56%

RSI (14)

47.0

vs 50D SMA

−0.11%

vs 200D SMA

−6.04%

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

0.87x

Quick Ratio

0.68x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.09

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

5.84B

Net Income (TTM)

−841.27M

Op. CF (TTM)

316.70M

Latest newsMore news →

Blue Sail Medical signed a share transfer agreement to repurchase 16.39% of Blue Sail Baisheng's equity, making it a wholly-owned subsidiary again.21d ago

Blue Sail Medical transferred its 100% equity in Wuhan Bikai'er to Mingde Bio-Tech for 190 million yuan; the transaction has been completed and Wuhan Bikai'er is no longer consolidated into Blue Sail Medical's financial statements.35d ago

Similar companies

创元科技000551.SZ 恒而达300946.SZ 豪美新材002988.SZ 红宝丽002165.SZ 金沃股份300984.SZ 回天新材300041.SZ Find similar companies →

Latest newsMore news →

Blue Sail Medical signed a share transfer agreement to repurchase 16.39% of Blue Sail Baisheng's equity, making it a wholly-owned subsidiary again.21d ago Blue Sail Medical transferred its 100% equity in Wuhan Bikai'er to Mingde Bio-Tech for 190 million yuan; the transaction has been completed and Wuhan Bikai'er is no longer consolidated into Blue Sail Medical's financial statements.35d ago